Seven Bridge Genomics A new subsidiary, the Unified Patient Network (UPN), was established to promote clinical research and collaboration between participating health systems and biopharmaceutical companies, with a focus on advancing precision medicine and improving patient care.
The Washington University School of Medicine in St. Louis and its affiliated health system BJC HealthCare is the first academic health system to join UPN as a founding member. UPN also collaborates with Genome Medical, a leading provider of genetics and genomics nursing telemedicine.
UPN will work in many disease states and treatment areas, including rare and complex neurodegenerative diseases, mental diseases and autoimmune diseases, as well as common diseases such as cancer, heart disease and diabetes. The data will be collected from patients in multiple health systems and used as part of research approved by the Institutional Review Board (IRB) to understand how genes promote or prevent various diseases and influence patient response to treatment.
UPN works closely with Seven Bridges to use Seven Bridges’ highly secure R&D ecosystem as an interoperability infrastructure for the network community, and uses ARIA™ to scientifically realize a hierarchical exploration and analysis intelligence system for the complex cohort of millions of patients. The content will only be provided to qualified researchers as part of the IRB-approved research, jointly agreed by UPN and health system members, using the verified security, identity verification and authorization protocols and technologies of Seven Bridges.
Information about UPN, click here.
Karum Health Announced that Bryan Chen has been appointed as Senior Vice President of User Growth. As an early employee and former executive of Vida Health, as the head of business development and strategy to accelerate the development of this digital health company, Chen will work across departments and across various functions of Carrum Health to promote user growth and COE utilization.
Sach Jain, CEO and founder of Carrum Health, said: “Carrum Health is accelerating the transition to results-based care, and we want to ensure that our members can optimize their healthcare experience by receiving the highest quality and most affordable care.” As a multifaceted executive, Chen brings unique experience and he has been at the forefront of the digital health revolution. He will use this expertise to ensure the success of our marketing, suppliers, patients, customers, and data team collaboration Work to provide our members with the most impactful experience.”
Chen’s hiring closely followed the hiring of other key executives last quarter, including former Google executives Palaf Shada Join chief platform officer and former consumer healthcare executive Randy K. Hawkins, MD Join the Chief Medical Officer.Earlier this month, Carrum Health was recognized by a group of innovative digital health startups and nominated as CB Insights Digital Health 150.
In order to reduce discrimination and strengthen compliance supervision, CMS will implement new Medicare Advantage rewards and incentives on January 1, 2022, which will require the plan to quickly adjust its incentive plan, otherwise it will face potential sanctions due to violations. Are you ready for these changes? For more information, read the latest article by James Haskins, Director of Government Projects, Healthy mine.
To read more, click here.
Norwest Venture Partners Already closed $3 billion Fund, Norwest Venture Partners XVI, LP. The new fund will invest in high-impact companies, from early to late venture capital and growth businesses across the healthcare, consumer and corporate sectors. NVP XVI makes the total capital managed by the company reach $12.5 billion.
Since the last fund closed in November 2019, it has invested in healthcare companies such as Devoro Medical and VisitPay.
To read more, click here.
Stratos Laboratory, A Philadelphia-based medical technology company and INVEST Digital Health Pitch Perfect Winner The company has developed a wearable device to detect lung sounds in patients with asthma, COPD and other respiratory diseases, and has added a Procter & Gamble healthcare executive to its board of directors.
When Steve Bishop was the CEO of Procter & Gamble’s healthcare business, he expanded the business through organic growth and mergers and acquisitions.
Strados Labs recently received the CE mark for the company’s RESP smart sensor platform for respiratory health. Last year, it received an FDA II category 510(k) RESP approval. In addition to targeting asthma, chronic obstructive pulmonary disease and infectious respiratory diseases, Strados also plans to increase heart failure by the end of 2022.
In an interview with MedCity News, CEO Nick Delmonico said that the device is suitable for more and more technology adoption, which supports decentralized clinical trials, and patients participate in drug research at home without having to go to the clinical site.
To read more, click here.
picture: Aquindo, Getty Images
